SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation ...

Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find ...

The gene therapy for neurological diseases market is poised for growth due to rising neurological disorder prevalence, demand ...

Mary Brunkow of the Seattle-based Institute for Systems Biology, Fred Ramsdell of Sonoma Biotherapeutics, and David Baker of the UW's Institute for Protein Design were honored for their research.

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...

The death of William (Bill) Rutter at the grand old age of 97 in July reminded me to remember not only him, but several of the other pioneers of our industry—lest we should forget them.

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...